13.9 Percent of Older Adults Meet Federal Physical Activity Guidelines
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 2, 2024 -- Overall, 13.9 percent of adults age 65 years and older met the federal physical activity guidelines for both aerobic and muscle-strengthening activities in 2022, according to a study published online Nov. 26 in the National Health Statistics Reports, a publication from the National Center for Health Statistics.
Nazik Elgaddal and Ellen A. Kramarow, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, used data from the 2022 National Health Interview Survey to estimate the percentage of adults aged 65 years and older who met the U.S. Department of Health and Human Services 2018 Federal Physical Activity Guidelines for Americans for aerobic and muscle-strengthening activities.
The researchers found that in 2022, 13.9 percent of adults aged 65 years and older met federal physical activity guidelines for both aerobic and muscle-strengthening activities. The likelihood of meeting the guidelines was higher among men, White non-Hispanic adults, and those living in metropolitan areas (16.9, 15.2, and 14.7 percent, respectively). There was an increase seen in the percentage meeting the federal physical activity guidelines with increasing education levels and family income and a decrease with the number of chronic conditions. Compared with those reporting good, very good, or excellent health, older adults who reported poor health status had the lowest percentage meeting the guidelines. Compared with adults with disabilities, those without disabilities were three times more likely to meet the federal physical activity guidelines (15.9 versus 5.0 percent).
"Understanding the patterns of physical activity for adults age 65 and older may help inform interventions to promote healthy aging," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-12-03 12:00
Read more
- FDA Approves Yesintek (ustekinumab-kfce), a Biosimilar to Stelara
- Supreme Court Won't Hear Big Tobacco's Challenge to Cigarette Warning Labels
- 22 Pesticides Linked to Prostate Cancer Risk
- Study Finds GLP-1 Meds, such as Ozempic, Wegovy, Can Also Help the Kidneys
- Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use Disorder
- Estimated 100,429 U.S. Youth Living With Pediatric Inflammatory Bowel Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions